$SRT (-1,57 %) It's been sitting like a dead weight in my portfolio since February 2025. A friend recommended it to me back then, and I jumped in without doing much research of my own. Right now, I’m down about 45%.
Now I’ve read up a bit on the company and looked at the current and projected figures, and the projections in particular look good:
https://de.marketscreener.com/kurs/aktie/SARTORIUS-AG-436557/finanzen/
2025 marked the turnaround, and things are expected to pick up starting in 2026:
2025 2026 2027
Revenue 4.6% 6% 9.45%
EBITDA 11.28% 6.8% 12.69%
FCF -31% 13.4% 31.9%
To me, this looks like a good turnaround case, so I’m considering holding onto my position for now and waiting it out—or possibly buying more if necessary.
Of 20 analysts, 14 see a buy signal with an average price target of €266. That would be a nice boost.
What does the community think $SRT (-1,57 %) ? Should we steer clear of biopharma in Germany, or do you see a case here as well? Is it better to take the loss? Should we wait for the trend to turn or even add to our position?
As of July 1, 2026, 4:30 p.m.
Price: €188.90
